Close Menu

On Stage and in Song

As part of his 2012 TedMed talk, the US National Institutes of Health Director Francis Collins says that the time between understanding the molecular cause of a disease and developing a drug to treat that disease is too long, and the process is too expensive. Collins further suggests that drugs that have been shown to be safe in humans — though not effective for their original target diseases — could be repurposed for other diseases, as the new National Center for Advancing Translational Sciences is aiming to do.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.